Key facts
- Waybridge Health’s last known valuation is $12.8M.
- It has raised $6.1M across 1 recorded rounds; the latest was Seed Round ($2.6M) in Sep 2025.
- Waybridge Health has filed 1 Form D with the SEC, most recently Sep 2025 ($2.6M sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Waybridge Health
Funding rounds
1 roundsAbout Waybridge Health
Provider of interventional psychiatry services designed to treat chronic depression and mood disorders through advanced clinical methods. The company offers therapies and medication management in a supportive setting under direct medical supervision, enabling individuals experiencing persistent mental health conditions to access evidence-based treatments that improve emotional well-being, reduce symptoms, and enhance overall quality of life.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2023
- Employees
- 8
- Website
- waybridgeclinics.com/
- Ownership
- Privately Held (backing)
Waybridge Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Waybridge Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Waybridge Health in its N-PORT filings yet. We sweep new filings monthly.